Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,049 | 3,383 | 4,107 | 5,022 | 2,787 |
| Marketable Securities | 0 | 0 | N/A | 0 | 50 |
| Receivables | 28 | 42 | 79 | 92 | 76 |
| Inventories | 26 | 28 | N/A | N/A | N/A |
| TOTAL | $3,209 | $3,956 | $4,995 | $6,438 | $4,404 |
| Non-Current Assets | |||||
| PPE Net | 164 | 143 | 6 | 6 | 6 |
| Investments And Advances | 703 | 448 | 475 | 800 | 62 |
| Intangibles | 5,902 | 5,856 | 4,614 | 4,789 | N/A |
| TOTAL | $6,769 | $6,447 | $5,095 | $5,596 | $69 |
| Total Assets | $9,978 | $10,403 | $10,090 | $12,034 | $4,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 928 | 394 | 106 | 172 | 728 |
| TOTAL | $928 | $394 | $106 | $172 | $728 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $928 | $394 | $106 | $172 | $728 |
| Shareholders' Equity | |||||
| Common Shares | 19,354 | 19,329 | 17,892 | 17,892 | 7,147 |
| Retained earnings | -13,546 | -11,676 | -9,957 | -7,543 | -4,660 |
| Other shareholders' equity | 3,243 | 2,357 | 2,050 | 1,514 | 1,258 |
| TOTAL | $9,050 | $10,010 | $9,984 | $11,862 | $3,745 |
| Total Liabilities And Equity | $9,978 | $10,403 | $10,090 | $12,034 | $4,473 |